Document Detail

Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.
MedLine Citation:
PMID:  12511718     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) are a common cause of hospital admission. Many exacerbations are believed to be due to upper and/or lower respiratory tract viral infections, but the incidence of these infections in patients with COPD is still undetermined. METHODS: Respiratory syncytial virus (RSV), influenza A and B, parainfluenza 3, and picornaviruses were detected by nested reverse transcription polymerase chain reaction (RT-PCR) in upper (nasal lavage) and lower respiratory tract specimens (induced sputum). In a 2:1 case-control set up, 85 hospitalised patients with AE-COPD and 42 patients with stable COPD admitted for other medical reasons were studied. RESULTS: Respiratory viruses were found more often in sputum and nasal lavage of patients with AE-COPD (48/85, 56%) than in patients with stable COPD (8/42, 19%, p<0.01). The most common viruses were picornaviruses (21/59, 36%), influenza A (15/59, 25%), and RSV (13/59, 22%). When specimens were analysed separately, this difference was seen in induced sputum (exacerbation 40/85 (47%) v stable 4/42 (10%), p<0.01) but was not significant in nasal lavage (exacerbation 26/85 (31%) v stable 7/42 (17%), p=0.14). In patients with AE-COPD, fever was more frequent in those in whom viruses were detected (12/48, 25%) than in those in whom viruses were not detected (2/37, 5%, p=0.03). CONCLUSION: Viral respiratory pathogens are found more often in respiratory specimens of hospitalised patients with AE-COPD than in control patients. Induced sputum detects respiratory viruses more frequently than nasal lavage in these patients. These data indicate that nasal lavage probably has no additional diagnostic value to induced sputum in cross-sectional studies on hospitalised patients with AE-COPD and that the role of viral infection in these patients is still underestimated.
G Rohde; A Wiethege; I Borg; M Kauth; T T Bauer; A Gillissen; A Bufe; G Schultze-Werninghaus
Related Documents :
25144168 - Visual function, traumatic brain injury, and posttraumatic stress disorder.
9426078 - Measurement of ct lung density in patients with chronic asthma.
22136828 - The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: ho...
12166588 - Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis.
22136198 - Effectiveness of biweekly low-dosage peginterferon treatment on the improvement of seru...
10659568 - Fast liver alkaline phosphatase isoenzyme in diagnosis of malignant biliary obstruction.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Thorax     Volume:  58     ISSN:  0040-6376     ISO Abbreviation:  Thorax     Publication Date:  2003 Jan 
Date Detail:
Created Date:  2003-01-03     Completed Date:  2003-02-05     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0417353     Medline TA:  Thorax     Country:  England    
Other Details:
Languages:  eng     Pagination:  37-42     Citation Subset:  IM    
University Hospital Bergmannsheil, Department of Internal Medicine, Division of Pneumology, Allergology and Sleep Medicine, D-44789 Bochum, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Case-Control Studies
Middle Aged
Nasal Lavage Fluid / virology
Prospective Studies
Pulmonary Disease, Chronic Obstructive / drug therapy,  physiopathology,  virology*
Reverse Transcriptase Polymerase Chain Reaction
Sputum / virology
Virus Diseases / complications*,  drug therapy,  physiopathology
Vital Capacity / physiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Self-management of asthma in general practice, asthma control and quality of life: a randomised cont...
Next Document:  Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction.